Lv5
1142 积分 2023-10-30 加入
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma
7小时前
待确认
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
Oncolytic viruses as anticancer agents: clinical progress and remaining challenges
1个月前
已完结
Therapy with oncolytic viruses: progress and challenges
1个月前
已完结
Cancer vaccines as enablers of immunotherapy
1个月前
已完结
mRNA vaccine in cancer therapy: Current advance and future outlook
1个月前
已完结
Recent advances in therapeutic cancer vaccines
1个月前
已完结
Cancer vaccines and the future of immunotherapy
1个月前
已完结
Cancer mRNA vaccines: clinical application progress and challenges
1个月前
已完结
Cancer mRNA vaccines: clinical advances and future opportunities
1个月前
已完结
皖公网安备34019202002308
